|
Re: Back to the drawing board for triple-negative breast cancer targets, researchers propose new combo approach.
|
4
|
Zenith Epigenetics
|
Apr 01, 2020 03:58PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 05:18PM
|
|
Money
|
1
|
Resverlogix Corp.
|
Mar 31, 2020 03:35PM
|
|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 08:18AM
|
|
Re: National Kidney Foundation -Abstract: BOM
|
2
|
Resverlogix Corp.
|
Mar 30, 2020 03:44PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
Mar 30, 2020 07:01AM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Mar 29, 2020 03:36PM
|
|
Finance
|
5
|
Resverlogix Corp.
|
Mar 29, 2020 12:48PM
|
|
Bear
|
1
|
Resverlogix Corp.
|
Mar 28, 2020 09:08AM
|
|
Re: #Covid19 Interview of Nevan Krogan, PDF of article
|
2
|
Resverlogix Corp.
|
Mar 27, 2020 12:43PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 11:31AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 26, 2020 03:45PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
5
|
Resverlogix Corp.
|
Mar 26, 2020 03:12PM
|
|
Excitement
|
2
|
Resverlogix Corp.
|
Mar 26, 2020 10:41AM
|
|
Re: Doom and gloom or meh....
|
2
|
Resverlogix Corp.
|
Mar 25, 2020 04:03PM
|
|
Re: Doom and gloom or meh....
|
4
|
Resverlogix Corp.
|
Mar 25, 2020 03:32PM
|
|
Re: You gotta love Canadians.....
|
1
|
Resverlogix Corp.
|
Mar 25, 2020 11:26AM
|
|
Re: Trying to be realistic here
|
1
|
Resverlogix Corp.
|
Mar 25, 2020 10:56AM
|
|
Re: This Covid 19 possibility has
|
2
|
Resverlogix Corp.
|
Mar 25, 2020 08:56AM
|
|
Hype
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 05:36PM
|
